Anticoagulation With Otamixaban and Ischemic Events in Non-ST-Segment Elevation Acute Coronary Syndromes The TAO Randomized Clinical Trial

Steg, Philippe; Mehta, Shamir; Pollack, Charles; Bode, Christoph; Cohen, Marc; French, William; Hoekstra, James; Rao, Sunil; Ruzyllo, Witold; Ruiz-Nodar, Juan; Sabate, Manel; Widimsky, Petr; Kiss, Robert; Navarro Estrada, Jose; Hod, Hanoch; Kerkar, Prafulla; Guneri, Sema; Sezer, Murat; Ruda, Mikhail; Nicolau, Jose; Cavallini, Claudio; Ebrahim, Iftikhar; Petrov, Ivo; Kim, Jae-Hyung; Jeong, Myung-Ho; Ramos Lopez, Gabriel; Laanmets, Peep; Kovar, Frantisek; Gaudin, Christophe; Fanouillere, Karen; Minini, Pascal; Hoffman, Elaine; Moryusef, Angele; Wiviott, Stephen; Sabatine, Marc

doi:10.1001/jama.2013.277165

Anticoagulation With Otamixaban and Ischemic Events in Non-ST-Segment Elevation Acute Coronary Syndromes The TAO Randomized Clinical Trial

Steg P. G., Mehta S. R., Pollack C. V., Bode C., Cohen M., French W. J., ...Daha Fazla

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, cilt.310, sa.11, ss.1145-1155, 2013 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 310 Sayı: 11
Basım Tarihi: 2013
Doi Numarası: 10.1001/jama.2013.277165
Dergi Adı: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1145-1155
İstanbul Üniversitesi Adresli: Evet

Özet

IMPORTANCE The optimal anticoagulant for patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) managed with an invasive strategy remains controversial.